- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Almirall (ALM)
Almirall stock price live, this page displays BME ALM stock exchange data. View the ALM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Almirall real time stock price chart below.
What Is the Almirall Stock Price Today?
The Almirall stock price today is 11.260.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is "ALM."
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid stock exchange.
Is Almirall a Good Stock to Buy?
Determining whether Almirall—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALM quote. (ISIN: ES0157097017)
What Is the Almirall Stock Price Today?
The Almirall stock price today is 11.260.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is "ALM."
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid stock exchange.
Is Almirall a Good Stock to Buy?
Determining whether Almirall—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALM quote. (ISIN: ES0157097017)
11.260
-0.020(-0.18%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.260
11.260
52 wk Range
10.060
13.980
ALM is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.26011.260
52 wk Range
10.06013.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
14.508
Upside
+28.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
10 Buy
2 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.508
(+28.85% Upside)
Almirall Earnings Call Summary for Q2/2026
- Almirall H1 2026 revenue rose 7.5% to EUR 603M; EBITDA margin hit 25%, reaching 2028 target 2.5 years early; free cash flow improved to EUR 33M.
- Biologics drove growth: Ilumetri sales up 10.5% to EUR 125M, Ebglyss nearly doubled to EUR 85M; gross margin reached 64.6% amid portfolio optimization.
- Company reaffirmed FY 2026 guidance of 9-12% sales growth and EUR 270-290M EBITDA, expecting momentum to build progressively in H2.
- Management comfortable with Ilumetri consensus of EUR 260-262M and Ebglyss EUR 190-193M for 2026; EVOLVE PSO study for 200mg dose to start year-end.
- Key risks include Germany pricing reform, rising royalty tiers on Ilumetri, and increased R&D/SG&A spending expected to pressure margins later in year.
Last Updated: 07/24/2026, 05:02 PM
Read Full TranscriptEarnings
Latest Release
Jul 24, 2026
EPS / Forecast
-- / 0.09
Revenue / Forecast
312M / 313.14M
Compare ALM to Peers and Sector
Metrics to compare | ALM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 41.9x | 16.1x | −0.4x | |
PEG Ratio | 0.24 | −0.10 | 0.00 | |
Price/Book | 1.6x | 5.1x | 2.6x | |
Price / LTM Sales | 2.1x | 3.3x | 2.9x | |
Upside (Analyst Target) | 26.1% | 23.4% | 56.8% | |
Fair Value Upside | Unlock | 17.0% | 8.9% | Unlock |
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations. It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage. It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Almirall (ALM) Stock Price Today?
The Almirall stock price today is 11.260 EUR.
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid Stock Exchange.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is "ALM."
Does Almirall Pay Dividends? What’s The Current Dividend Yield?
The Almirall dividend yield is 1.35%.
What Is the Almirall Market Cap?
As of today, Almirall market cap is 2.450B EUR.
What Is Almirall's Earnings Per Share (TTM)?
The Almirall EPS (TTM) is 0.276.
When Is the Next Almirall Earnings Date?
Almirall will release its next earnings report on Nov 09, 2026.
From a Technical Analysis Perspective, Is ALM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Almirall Stock Split?
Almirall has split 4 times.
How Many Employees Does Almirall Have?
Almirall has 2108 employees.
What is the current trading status of Almirall (ALM)?
As of Jul 28, 2026, Almirall (ALM) is trading at a price of 11.260 EUR, with a previous close of 11.280 EUR. The stock has fluctuated within a day range of 11.260 EUR to 11.260 EUR, while its 52-week range spans from 10.060 EUR to 13.980 EUR.
What Is Almirall (ALM) Price Target According to Analysts?
The average 12-month price target for Almirall is 14.508 EUR, with a high estimate of 17.5 EUR and a low estimate of 12.5 EUR. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +28.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.